771 related articles for article (PubMed ID: 30518596)
21. Dopaminergic neurotransmission dysfunction induced by amyloid-β transforms cortical long-term potentiation into long-term depression and produces memory impairment.
Moreno-Castilla P; Rodriguez-Duran LF; Guzman-Ramos K; Barcenas-Femat A; Escobar ML; Bermudez-Rattoni F
Neurobiol Aging; 2016 May; 41():187-199. PubMed ID: 27103531
[TBL] [Abstract][Full Text] [Related]
22. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
Mol Brain; 2014 Sep; 7():65. PubMed ID: 25213836
[TBL] [Abstract][Full Text] [Related]
23. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.
Origlia N; Righi M; Capsoni S; Cattaneo A; Fang F; Stern DM; Chen JX; Schmidt AM; Arancio O; Yan SD; Domenici L
J Neurosci; 2008 Mar; 28(13):3521-30. PubMed ID: 18367618
[TBL] [Abstract][Full Text] [Related]
24. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
25. Conditional Deletion of
Salazar SV; Gallardo C; Kaufman AC; Herber CS; Haas LT; Robinson S; Manson JC; Lee MK; Strittmatter SM
J Neurosci; 2017 Sep; 37(38):9207-9221. PubMed ID: 28842420
[TBL] [Abstract][Full Text] [Related]
26. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein.
Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM
Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719
[TBL] [Abstract][Full Text] [Related]
27. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
28. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
[TBL] [Abstract][Full Text] [Related]
29. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
Smith LA; McMahon LL
Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
[TBL] [Abstract][Full Text] [Related]
30. A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity.
Bouvet P; de Gea P; Aimard M; Chounlamountri N; Honnorat J; Delcros JG; Salin PA; Meissirel C
Aging Cell; 2023 Sep; 22(9):e13907. PubMed ID: 37415305
[TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
33. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
35. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.
Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM
Neuron; 2003 Jul; 39(3):409-21. PubMed ID: 12895417
[TBL] [Abstract][Full Text] [Related]
36. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z
Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032
[TBL] [Abstract][Full Text] [Related]
37. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
38. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
39. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
40. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
